Tag: Viabahn

Two-year data from Viabahn BX IDE trial “promising”

The 24-month data from the Viabahn BX Flex balloon-expandable stent (Gore) investigational device exemption (IDE) trial are “promising” with sustained clinical and patency benefits...

First implant of Viabahn VBX stent graft completed

Houston Methodist Hospital has become the first US institution to implant the newly FDA-approved Viabahn VBX balloon expandable endoprosthesis (VBX stent graft; Gore), to...

One-year Japanese results support use of the Viabahn endoprosthesis to treat...

Gore has announced positive results from a prospective, multicentre investigational device exemption (IDE) clinical study of the Viabahn endoprosthesis with heparin bioactive surface in...

Gore Viabahn endoprosthesis celebrates 20 years since introduction

Gore is celebrating the 20th anniversary of the introduction of the Viabahn endoprosthesis; its stent graft for the treatment of complex peripheral vascular disease....